Post-IPO Equity - Liquidia Technologies
Investment Firm
Overview
Liquidia Technologies is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics.
Announced Date
Apr 13, 2021
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
Participant Investors
3
| Investor Name |
|---|
Round Details and Background
Liquidia Technologies raised $21700000 on 2021-04-13 in Post-IPO Equity
Liquidia Technologies is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics.
Company Funding History
19
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jul 13, 2010 |  Series C - Liquidia Technologies | 5 | - | 5.0M |
| Jun 14, 2006 | Series A - Liquidia Technologies | 7 | - | 6.0M |
| Dec 17, 2009 | Grant - Liquidia Technologies | 1 | - | 3.0M |
| Jan 19, 2010 | Series C - Liquidia Technologies | 5 | - | 20.0M |
Recent Activity
There is no recent news or activity for this profile.